Sangamo Therapeutics, Inc. (SGMO)
USD 0.58
(-11.68%)
USD 0.58
(-11.68%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -45.32 Million USD | 55.3% |
| 2022 | 99.19 Million USD | -2.05% |
| 2021 | 101.26 Million USD | 262.14% |
| 2020 | -62.45 Million USD | -43.59% |
| 2019 | -43.49 Million USD | -43.01% |
| 2018 | -30.41 Million USD | -4.3% |
| 2017 | -29.16 Million USD | 36.92% |
| 2016 | -46.22 Million USD | -67.56% |
| 2015 | -27.58 Million USD | -153.72% |
| 2014 | -10.87 Million USD | 15.35% |
| 2013 | -12.84 Million USD | -27.77% |
| 2012 | -10.05 Million USD | -197.43% |
| 2011 | 10.31 Million USD | -50.4% |
| 2010 | 20.8 Million USD | -6.23% |
| 2009 | 22.18 Million USD | 37.08% |
| 2008 | 16.18 Million USD | 77.91% |
| 2007 | 9.09 Million USD | 15.38% |
| 2006 | 7.88 Million USD | 217.43% |
| 2005 | 2.48 Million USD | 88.9% |
| 2004 | 1.31 Million USD | -49.01% |
| 2003 | 2.57 Million USD | -40.62% |
| 2002 | 4.34 Million USD | -11.1% |
| 2001 | 4.88 Million USD | -43.62% |
| 2000 | 8.66 Million USD | 198.79% |
| 1999 | 2.9 Million USD | 42.3% |
| 1998 | 2.03 Million USD | 76.91% |
| 1997 | 1.15 Million USD | 82.28% |
| 1996 | 632 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -2.21 Million USD | -8.41% |
| 2024 Q1 | -2.04 Million USD | -117.55% |
| 2023 Q4 | -940 Thousand USD | -731.86% |
| 2023 Q1 | 154.46 Million USD | 546.66% |
| 2023 Q3 | -113 Thousand USD | -104.38% |
| 2023 Q2 | 2.57 Million USD | -98.33% |
| 2023 FY | 154.04 Million USD | 55.3% |
| 2022 Q4 | 23.88 Million USD | 2.03% |
| 2022 Q3 | 23.41 Million USD | -11.64% |
| 2022 FY | 99.19 Million USD | -2.05% |
| 2022 Q1 | 25.39 Million USD | 0.7% |
| 2022 Q2 | 26.49 Million USD | 4.31% |
| 2021 Q2 | -32.21 Million USD | -6.83% |
| 2021 Q1 | -30.15 Million USD | -13.54% |
| 2021 FY | 101.26 Million USD | 262.14% |
| 2021 Q3 | -33.93 Million USD | -5.34% |
| 2021 Q4 | 25.22 Million USD | 174.32% |
| 2020 Q3 | 12.47 Million USD | 162.47% |
| 2020 Q1 | -28.4 Million USD | -271.91% |
| 2020 Q2 | -19.97 Million USD | 29.69% |
| 2020 Q4 | -26.55 Million USD | -312.87% |
| 2020 FY | -62.45 Million USD | -43.59% |
| 2019 Q4 | 16.52 Million USD | 215.3% |
| 2019 Q2 | -18.9 Million USD | 29.4% |
| 2019 Q1 | -26.77 Million USD | -317.31% |
| 2019 FY | -43.49 Million USD | -43.01% |
| 2019 Q3 | -14.33 Million USD | 24.21% |
| 2018 Q4 | -6.41 Million USD | -22.28% |
| 2018 FY | -30.41 Million USD | -4.3% |
| 2018 Q1 | -10.91 Million USD | -73.17% |
| 2018 Q2 | -7.83 Million USD | 28.15% |
| 2018 Q3 | -5.24 Million USD | 33.05% |
| 2017 FY | -29.16 Million USD | 36.92% |
| 2017 Q3 | -6.61 Million USD | 1.75% |
| 2017 Q1 | -9.51 Million USD | -91.57% |
| 2017 Q2 | -6.73 Million USD | 29.27% |
| 2017 Q4 | -6.3 Million USD | 4.73% |
| 2016 FY | -46.22 Million USD | -67.56% |
| 2016 Q1 | -11.32 Million USD | -5.68% |
| 2016 Q2 | -15.75 Million USD | -39.1% |
| 2016 Q3 | -14.18 Million USD | 9.95% |
| 2016 Q4 | -4.96 Million USD | 64.98% |
| 2015 Q1 | -1.48 Million USD | -3717.95% |
| 2015 Q2 | -7.26 Million USD | -387.58% |
| 2015 Q3 | -8.12 Million USD | -11.91% |
| 2015 Q4 | -10.71 Million USD | -31.88% |
| 2015 FY | -27.58 Million USD | -153.72% |
| 2014 Q1 | -3.96 Million USD | -1.48% |
| 2014 Q4 | -39 Thousand USD | 99.01% |
| 2014 Q3 | -3.92 Million USD | -27.58% |
| 2014 FY | -10.87 Million USD | 15.35% |
| 2014 Q2 | -3.07 Million USD | 22.49% |
| 2013 Q2 | -2.34 Million USD | 34.83% |
| 2013 Q1 | -3.59 Million USD | -140.27% |
| 2013 FY | -12.84 Million USD | -27.77% |
| 2013 Q4 | -3.9 Million USD | -30.47% |
| 2013 Q3 | -2.99 Million USD | -27.82% |
| 2012 Q3 | -2.66 Million USD | -158.22% |
| 2012 Q1 | 3.24 Million USD | -31.72% |
| 2012 FY | -10.05 Million USD | -197.43% |
| 2012 Q4 | 8.93 Million USD | 435.41% |
| 2012 Q2 | 4.57 Million USD | 41.09% |
| 2011 Q2 | 1.51 Million USD | -31.18% |
| 2011 FY | 10.31 Million USD | -50.4% |
| 2011 Q4 | 4.74 Million USD | 155.68% |
| 2011 Q1 | 2.2 Million USD | -53.08% |
| 2011 Q3 | 1.85 Million USD | 22.66% |
| 2010 FY | 20.8 Million USD | -6.23% |
| 2010 Q1 | 6.64 Million USD | -35.08% |
| 2010 Q2 | 6.52 Million USD | -1.85% |
| 2010 Q3 | 2.94 Million USD | -54.9% |
| 2010 Q4 | 4.68 Million USD | 59.33% |
| 2009 FY | 22.18 Million USD | 37.08% |
| 2009 Q2 | 4.72 Million USD | 49.7% |
| 2009 Q1 | 3.15 Million USD | -53.8% |
| 2009 Q4 | 10.24 Million USD | 152.06% |
| 2009 Q3 | 4.06 Million USD | -14.03% |
| 2008 Q2 | 2.84 Million USD | 2.78% |
| 2008 Q1 | 2.76 Million USD | -0.07% |
| 2008 Q4 | 6.83 Million USD | 82.48% |
| 2008 Q3 | 3.74 Million USD | 31.77% |
| 2008 FY | 16.18 Million USD | 77.91% |
| 2007 Q2 | 2.58 Million USD | 81.72% |
| 2007 FY | 9.09 Million USD | 15.38% |
| 2007 Q1 | 1.42 Million USD | -35.16% |
| 2007 Q4 | 2.76 Million USD | 19.01% |
| 2007 Q3 | 2.32 Million USD | -10.02% |
| 2006 FY | 7.88 Million USD | 217.43% |
| 2006 Q3 | 1.77 Million USD | 0.11% |
| 2006 Q2 | 1.77 Million USD | -16.81% |
| 2006 Q1 | 2.13 Million USD | 52.9% |
| 2006 Q4 | 2.19 Million USD | 23.27% |
| 2005 FY | 2.48 Million USD | 88.9% |
| 2005 Q2 | 418 Thousand USD | 63.28% |
| 2005 Q3 | 412 Thousand USD | -1.44% |
| 2005 Q4 | 1.39 Million USD | 239.08% |
| 2005 Q1 | 256 Thousand USD | 28.0% |
| 2004 FY | 1.31 Million USD | -49.01% |
| 2004 Q2 | 132 Thousand USD | -83.72% |
| 2004 Q1 | 811 Thousand USD | -19.14% |
| 2004 Q4 | 200 Thousand USD | 16.28% |
| 2004 Q3 | 172 Thousand USD | 30.3% |
| 2003 Q4 | 1 Million USD | 97.83% |
| 2003 Q2 | 518 Thousand USD | -5.99% |
| 2003 Q1 | 551 Thousand USD | -77.64% |
| 2003 FY | 2.57 Million USD | -40.62% |
| 2003 Q3 | 507 Thousand USD | -2.12% |
| 2002 Q3 | 1.01 Million USD | 176.5% |
| 2002 Q4 | 2.46 Million USD | 143.48% |
| 2002 Q1 | 501 Thousand USD | -76.85% |
| 2002 Q2 | 366 Thousand USD | -26.95% |
| 2002 FY | 4.34 Million USD | -11.1% |
| 2001 Q3 | 739 Thousand USD | -45.18% |
| 2001 Q1 | 634 Thousand USD | -89.49% |
| 2001 Q4 | 2.16 Million USD | 192.83% |
| 2001 FY | 4.88 Million USD | -43.62% |
| 2001 Q2 | 1.34 Million USD | 112.62% |
| 2000 Q2 | 837 Thousand USD | -50.59% |
| 2000 FY | 8.66 Million USD | 198.79% |
| 2000 Q3 | 934 Thousand USD | 11.59% |
| 2000 Q4 | 6.03 Million USD | 545.72% |
| 2000 Q1 | 1.69 Million USD | 0.0% |
| 1999 FY | 2.9 Million USD | 42.3% |
| 1998 FY | 2.03 Million USD | 76.91% |
| 1997 FY | 1.15 Million USD | 82.28% |
| 1996 FY | 632 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 219.198% |
| Alkermes plc | 1.37 Billion USD | 103.297% |
| Agenus Inc. | 139.61 Million USD | 132.464% |
| Aptorum Group Limited | -1.11 Million USD | -3966.16% |
| Ardelyx, Inc. | 106.66 Million USD | 142.494% |
| Dyadic International, Inc. | 922.95 Thousand USD | 5010.846% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 315.208% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -25823.257% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -239.314% |
| Novavax, Inc. | 639.93 Million USD | 107.083% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 3.232% |
| Pyxis Oncology, Inc. | -2 Million USD | -2166.25% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -8671.234% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 338.014% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -102473.097% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -8500.569% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 53.852% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 5751.496% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -55174.39% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 133.507% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 675.848% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 53.249% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 102.986% |
| AlloVir, Inc. | -398 Thousand USD | -11288.191% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 118.828% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 10789.858% |
| Bicycle Therapeutics plc | -129.52 Million USD | 65.005% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 37870.833% |
| ChromaDex Corporation | 50.78 Million USD | 189.258% |
| Chimerix, Inc. | 324 Thousand USD | 14089.198% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -45.423% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 41.59% |
| CRISPR Therapeutics AG | 240.95 Million USD | 118.81% |
| Precision BioSciences, Inc. | 40.47 Million USD | 211.991% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 53.827% |
| Fortress Biotech, Inc. | 57.85 Million USD | 178.345% |
| Fortress Biotech, Inc. | 57.85 Million USD | 178.345% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 373.421% |
| ImmuCell Corporation | 4.39 Million USD | 1130.984% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 57.29% |
| Immix Biopharma, Inc. | -5468.00 USD | -828813.68% |
| Incyte Corporation | 3.44 Billion USD | 101.317% |
| Innoviva, Inc. | 261.06 Million USD | 117.362% |
| IO Biotech, Inc. | -756 Thousand USD | -5895.37% |
| Jaguar Health, Inc. | 7.72 Million USD | 686.807% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -6726.054% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 137.849% |
| ContextLogic Inc. | 59 Million USD | 176.822% |
| MiMedx Group, Inc. | 266.84 Million USD | 116.986% |
| MEI Pharma, Inc. | 49.32 Million USD | 191.887% |
| NextCure, Inc. | -3.68 Million USD | -1130.32% |
| Onconetix, Inc. | -1.12 Million USD | -3921.15% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -56.466% |
| Opthea Limited | 21.72 Thousand USD | 208778.637% |
| Psyence Biomedical Ltd. | -240.00 USD | -18885316.667% |
| Vaxcyte, Inc. | -75 Million USD | 39.567% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -78965.346% |
| Precigen, Inc. | 106 Thousand USD | 42859.434% |
| Pharming Group N.V. | 220.1 Million USD | 120.593% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 8900.971% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 4592.071% |
| PureTech Health plc | -1.6 Million USD | -2727.511% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 141.29% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 75.015% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -106.145% |
| Acelyrin, Inc. | -115 Thousand USD | -39313.043% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -450850.154% |
| Summit Therapeutics Inc. | -2.05 Million USD | -2110.976% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -7837.828% |
| Senti Biosciences, Inc. | -2.68 Million USD | -1589.34% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1218.86% |
| Elevation Oncology, Inc. | -39 Thousand USD | -116117.949% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -844.664% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -1049.783% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 255.601% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 9238.105% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -82309.091% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 143.54% |
| Seer, Inc. | 7.02 Million USD | 745.012% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1135.29% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 310.374% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -38151.85% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -31529.228% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 7542.529% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 137.622% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 114.45% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -906400.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 1860.878% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -89227.946% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 254.235% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -19436.638% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -9112.398% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -538.56% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -9451.254% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -435717.308% |
| Soligenix, Inc. | 97.31 Thousand USD | 46677.468% |
| Century Therapeutics, Inc. | -10.8 Million USD | -319.326% |
| Kura Oncology, Inc. | -849 Thousand USD | -5238.634% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 32.456% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -30733.333% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 145.765% |
| Autolus Therapeutics plc | -4.86 Million USD | -831.272% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 209.518% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -26879.167% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 147.85% |
| GRI Bio, Inc. | 10.84 Million USD | 518.089% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 1884.459% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -421.757% |
| IGM Biosciences, Inc. | -211.66 Million USD | 78.586% |
| INmune Bio, Inc. | 155 Thousand USD | 29341.935% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 173.177% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2909.047% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6889.702% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -154730.225% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 11374.876% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -2170.792% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -14380.831% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 147.983% |
| Verastem, Inc. | -62 Thousand USD | -73004.839% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 1961.396% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -17265.9% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 1597.357% |
| Histogen Inc. | 3.76 Million USD | 1302.574% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 7966.479% |
| Surrozen, Inc. | -27.23 Million USD | -66.452% |
| Organovo Holdings, Inc. | -5.38 Million USD | -741.065% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -3661.785% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -76.726% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 326.037% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -2289041.414% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 847.145% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -67417.242% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 129.281% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 31187.106% |
| Apollomics, Inc. | 127 Thousand USD | 35788.976% |
| Amarin Corporation plc | 165.54 Million USD | 127.38% |
| Mesoblast Limited | -9.81 Million USD | -361.793% |
| Turnstone Biologics Corp. | 16.5 Million USD | 374.597% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 58.978% |
| Synaptogenix, Inc. | -6347.00 USD | -714016.906% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -88772.549% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 128.088% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 102.579% |
| Better Therapeutics, Inc. | -2.72 Million USD | -1560.865% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 59.589% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 113.407% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -397208.906% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -624.042% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3990.704% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 719.363% |
| Insmed Incorporated | 239.63 Million USD | 118.914% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 1366.769% |
| OmniAb, Inc. | 14.66 Million USD | 409.027% |
| Alector, Inc. | -95.05 Million USD | 52.316% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 136.081% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -4.284% |
| Zai Lab Limited | 170.9 Million USD | 126.521% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 155.357% |
| Aura Biosciences, Inc. | -1.29 Million USD | -3400.0% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 34965.385% |
| Immunic, Inc. | -111 Thousand USD | -40733.333% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 385.89% |
| Veracyte, Inc. | 248.14 Million USD | 118.265% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.351% |
| FibroGen, Inc. | 128.9 Million USD | 135.162% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -8036247.518% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -288.493% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.334% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 11751.671% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 112.755% |
| TG Therapeutics, Inc. | 219.1 Million USD | 120.686% |
| Galecto, Inc. | -830 Thousand USD | -5360.843% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -3172.563% |
| Fortrea Holdings Inc. | 424 Million USD | 110.69% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 47.399% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -7893.827% |
| XBiotech Inc. | -1.74 Million USD | -2498.911% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3990.704% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 2.466% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 39.994% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 161.748% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 369.743% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 111.65% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 8.705% |
| Vaxxinity, Inc. | -2.23 Million USD | -1928.872% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 113.871% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -300.262% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 285.371% |
| NexImmune, Inc. | -1.02 Million USD | -4322.072% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 839451.852% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -537.872% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.401% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -67724.382% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1176.401% |
| Ainos, Inc. | -253.73 Thousand USD | -17763.266% |
| Pluri Inc. | 322 Thousand USD | 14176.087% |
| Prothena Corporation plc | -129.2 Million USD | 64.919% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 189.888% |
| Celularity Inc. | 6.75 Million USD | 770.984% |
| Rallybio Corporation | -150 Thousand USD | -30116.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | -39.004% |
| MeiraGTx Holdings plc | 287 Thousand USD | 15892.683% |
| Omeros Corporation | -69.77 Million USD | 35.045% |
| Humacyte, Inc. | -76.55 Million USD | 40.79% |
| Immunocore Holdings plc | 248.39 Million USD | 118.247% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -198.8% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 172.657% |
| Blueprint Medicines Corporation | 236.58 Million USD | 119.158% |
| CalciMedica, Inc. | -58 Thousand USD | -78046.552% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -3078.471% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 255.997% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -1493.706% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -46.849% |
| Pulmatrix, Inc. | -8.22 Million USD | -451.399% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -3773.932% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -11259.649% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 88.634% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 1732.989% |
| Cytokinetics, Incorporated | -322.59 Million USD | 85.95% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 5357.48% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -13191.789% |
| Vor Biopharma Inc. | -3.49 Million USD | -1197.967% |
| Roivant Sciences Ltd. | 109.23 Million USD | 141.493% |
| Evogene Ltd. | 1.39 Million USD | 3339.814% |
| ProKidney Corp. | -3.16 Million USD | -1330.262% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -3.218% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 761.003% |
| CorMedix Inc. | -205.56 Thousand USD | -21949.309% |
| BioLineRx Ltd. | 1.1 Million USD | 4190.704% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 42.387% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -137248.485% |
| Atai Life Sciences N.V. | -5000.00 USD | -906400.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -37094.627% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -47113.542% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -3163.139% |
| Sagimet Biosciences Inc. | 2 Million USD | 2366.25% |
| MediciNova, Inc. | 979.7 Thousand USD | 4726.393% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 46.246% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -47835.064% |
| GeoVax Labs, Inc. | -20.72 Million USD | -118.742% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 118.535% |
| Biomea Fusion, Inc. | -4.2 Million USD | -978.91% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 105.196% |
| Mereo BioPharma Group plc | 7.42 Million USD | 710.356% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -14520.968% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -377608.333% |
| Absci Corporation | -41.84 Million USD | -8.306% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -906400.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 40.653% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -1741.731% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 121.206% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -4716.684% |
| Allakos Inc. | -6.14 Million USD | -638.072% |
| Imunon, Inc. | -720 Thousand USD | -6195.095% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 34.308% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 109.524% |
| BioAtla, Inc. | -103.73 Million USD | 56.305% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -397208.906% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -25363.483% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 81.334% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -14473.955% |
| XOMA Corporation | 3.86 Million USD | 1273.919% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 35.329% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 406.374% |
| aTyr Pharma, Inc. | -2.38 Million USD | -1798.032% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 463.764% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -156193.103% |
| Viridian Therapeutics, Inc. | -1 Million USD | -4396.528% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 348653946.154% |
| Akari Therapeutics, Plc | -4000.00 USD | -1133025.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 107.117% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 23378.448% |
| UroGen Pharma Ltd. | 73.35 Million USD | 161.791% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -69.795% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 390496.21% |
| Orgenesis Inc. | -5.72 Million USD | -691.703% |
| Entera Bio Ltd. | -56 Thousand USD | -80837.5% |
| GH Research PLC | -315 Thousand USD | -14288.889% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -23881.481% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -8533.333% |
| Xencor, Inc. | -85.26 Million USD | 46.839% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -20411.184% |
| Replimune Group, Inc. | -2.65 Million USD | -1607.156% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -4426.905% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 125.486% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 23378.448% |
| Portage Biotech Inc. | -54 Thousand USD | -83835.185% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -47835.064% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -11922.546% |
| OncoCyte Corporation | 413 Thousand USD | 11074.576% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1008242.603% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -20416566.667% |
| Purple Biotech Ltd. | -196 Thousand USD | -23025.0% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 605.408% |
| scPharmaceuticals Inc. | 9.78 Million USD | 563.351% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -333.941% |
| HilleVax, Inc. | -2.15 Million USD | -2002.273% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -46626.804% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -301986.11% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -6685.18% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -196965.217% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -603737.382% |
| Savara Inc. | -44.26 Million USD | -2.402% |
| Curis, Inc. | 9.81 Million USD | 561.981% |
| Daré Bioscience, Inc. | 2.76 Million USD | 1736.564% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -36221.601% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -2521.457% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -19779.386% |
| BeiGene, Ltd. | 2.07 Billion USD | 102.18% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -1521.124% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 88.659% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 179.955% |
| Erasca, Inc. | -3.73 Million USD | -1114.496% |
| bluebird bio, Inc. | -4.03 Million USD | -1024.69% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -160524.424% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 102.38% |
| DBV Technologies S.A. | 15.72 Million USD | 388.18% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -160524.424% |
| Moderna, Inc. | 2.15 Billion USD | 102.103% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -4853.552% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 666.138% |
| Molecular Templates, Inc. | 50.39 Million USD | 189.939% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -8356.157% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 133.878% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -628.464% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -15.205% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 59.214% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1163.239% |
| MacroGenics, Inc. | 50.52 Million USD | 189.705% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -643.276% |
| Prime Medicine, Inc. | -147.9 Million USD | 69.355% |
| Aditxt, Inc. | -111.66 Thousand USD | -40491.976% |
| Adagene Inc. | 18.11 Million USD | 350.255% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 9387.91% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 132.328% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 128.717% |
| SciSparc Ltd. | 2.19 Million USD | 2163.98% |
| Vericel Corporation | 135.57 Million USD | 133.431% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -180845.347% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -146194.623% |
| Generation Bio Co. | -73.91 Million USD | 38.676% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -10271.854% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 182.984% |
| Invivyd, Inc. | -2.02 Million USD | -2134.961% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 84.934% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -43718.519% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 147.033% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 146.114% |
| ADMA Biologics, Inc. | 88.21 Million USD | 151.378% |
| Clene Inc. | 533 Thousand USD | 8603.752% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 287.999% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -4636.155% |
| GeoVax Labs, Inc. | -20.72 Million USD | -118.742% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 2379.93% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -23225.408% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 191.005% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -539.1% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -5321.651% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 154.337% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 62093.927% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 185.258% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 73.829% |
| Trevena, Inc. | 1.45 Million USD | 3215.12% |
| Surrozen, Inc. | -27.23 Million USD | -66.452% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -12739.943% |
| Cingulate Inc. | -582.91 Thousand USD | -7675.536% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -146109.677% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -130.088% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -598645.046% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -5044.722% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 106.659% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -4487.551% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -80346.204% |
| Kronos Bio, Inc. | 1.37 Million USD | 3403.571% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 15.542% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -15422.26% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -9181.937% |
| ImmunityBio, Inc. | -17.89 Million USD | -153.354% |
| Korro Bio, Inc. | -3.63 Million USD | -1148.623% |
| Kineta, Inc. | 5.43 Million USD | 934.254% |
| BioVie Inc. | -229.37 Thousand USD | -19660.046% |
| Codexis, Inc. | 57.33 Million USD | 179.054% |
| Celularity Inc. | 6.75 Million USD | 770.984% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1229.454% |
| Celcuity Inc. | -142.77 Thousand USD | -31646.421% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 89692.805% |
| Cibus, Inc. | 1.42 Million USD | 3287.412% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -12018.984% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -97.762% |
| IN8bio, Inc. | -2.5 Million USD | -1712.275% |
| Kodiak Sciences Inc. | -25.94 Million USD | -74.683% |
| Annexon, Inc. | -3.26 Million USD | -1287.358% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -2117.466% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -8.597% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 7182.031% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 105.822% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 126.206% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -2285.526% |
| Arcellx, Inc. | 108.27 Million USD | 141.859% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -40.026% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 157.226% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -114.282% |
| Moolec Science SA | -143.3 Thousand USD | -31528.345% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -7.106% |
| Geron Corporation | -123.5 Million USD | 63.3% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 1478.917% |
| Royalty Pharma plc | 1.79 Billion USD | 102.527% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 35.333% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1254744.961% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 19688.057% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 59.318% |
| Humacyte, Inc. | -76.55 Million USD | 40.79% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -4675.205% |
| 89bio, Inc. | -273 Thousand USD | -16502.564% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -3505.807% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -5244.929% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -36749.593% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 4150.492% |
| Notable Labs, Ltd. | 113 Thousand USD | 40210.619% |
| Liquidia Corporation | 14.6 Million USD | 410.445% |
| Mustang Bio, Inc. | -2.22 Million USD | -1937.079% |
| Immunovant, Inc. | -231 Thousand USD | -19521.212% |
| Quantum-Si incorporated | 488 Thousand USD | 9387.91% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 18.42% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -150983.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 2534.211% |
| Acasti Pharma Inc. | -11 Thousand USD | -411945.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -22051.141% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6889.702% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 72.942% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 4094.87% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -11796.325% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -2214.862% |
| PepGen Inc. | -1.18 Million USD | -3728.125% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -35588.976% |
| United Therapeutics Corporation | 2.07 Billion USD | 102.19% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -97.952% |
| Solid Biosciences Inc. | -76.56 Million USD | 40.8% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -54784.177% |
| Immuneering Corporation | -764.13 Thousand USD | -5831.52% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 68500.64% |
| Belite Bio, Inc | -399 Thousand USD | -11259.649% |
| XOMA Corporation | 3.86 Million USD | 1273.919% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -126.218% |
| Bionomics Limited | -434.44 Thousand USD | -10332.755% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -4120.205% |
| uniQure N.V. | 2.21 Million USD | 2146.275% |
| Cassava Sciences, Inc. | -89.42 Million USD | 49.314% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 50.771% |
| Forte Biosciences, Inc. | -9000.00 USD | -503511.111% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -5328.144% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -10271.854% |
| Altimmune, Inc. | -65.37 Million USD | 30.667% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 112.52% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -4120.205% |
| Compugen Ltd. | 31.45 Million USD | 244.095% |
| Peak Bio, Inc. | 367.76 Thousand USD | 12424.312% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 284.879% |
| Benitec Biopharma Inc. | 108 Thousand USD | 42067.593% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -58008.974% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -3667.664% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -2387.651% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -37988.235% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -3667.664% |
| Instil Bio, Inc. | -4.75 Million USD | -853.007% |
| argenx SE | 1.1 Billion USD | 104.089% |
| Immunome, Inc. | -8.9 Million USD | -408.869% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -2298.148% |
| Verona Pharma plc | -679.62 Thousand USD | -6569.129% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -25800.0% |
| Shattuck Labs, Inc. | -2.38 Million USD | -1800.419% |
| CervoMed Inc. | -1.29 Million USD | -3403.715% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -1783.049% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -848.817% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 1934.278% |
| Moolec Science SA | -143.3 Thousand USD | -31528.345% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -11008.252% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -1596.595% |
| AnaptysBio, Inc. | 14.78 Million USD | 406.644% |
| Design Therapeutics, Inc. | -537 Thousand USD | -8340.41% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -10514.754% |
| NeurAxis, Inc. | 2.15 Million USD | 2201.586% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 2212.069% |
| Lumos Pharma, Inc. | 2 Million USD | 2358.346% |
| Achilles Therapeutics plc | -4.73 Million USD | -857.989% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -25800.0% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -42790.939% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 243.167% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 5357.48% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -4291.957% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 0.49% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 105506.977% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -5413.99% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -344367.244% |
| Palisade Bio, Inc. | 246 Thousand USD | 18524.797% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -137248.485% |
| Beam Therapeutics Inc. | -59.67 Million USD | 24.043% |
| Neurogene Inc. | -3.26 Million USD | -1289.485% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 132.53% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1127.654% |
| Sesen Bio, Inc. | 40 Million USD | 213.313% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -15160.943% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1025.517% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -373.814% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 421.911% |
| Athira Pharma, Inc. | -969 Thousand USD | -4577.503% |
| Vaccinex, Inc. | -16 Million USD | -183.21% |
| HCW Biologics Inc. | -574.82 Thousand USD | -7785.022% |
| XOMA Corporation | 3.86 Million USD | 1273.919% |
| Nektar Therapeutics | 53.47 Million USD | 184.754% |
| Arvinas, Inc. | 71.8 Million USD | 163.127% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 45.693% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 27.798% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -13976.087% |
| Rezolute, Inc. | -36 Thousand USD | -125802.778% |
| Clene Inc. | 533 Thousand USD | 8603.752% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -3529884.424% |
| BeyondSpring Inc. | 1.75 Million USD | 2688.521% |
| Synlogic, Inc. | -1.92 Million USD | -2255.769% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -122400.0% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -615.809% |
| Peak Bio, Inc. | 367.76 Thousand USD | 12424.312% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -139.018% |
| Krystal Biotech, Inc. | 47.6 Million USD | 195.211% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 132.125% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1001.99% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -1650.528% |
| MannKind Corporation | 136.19 Million USD | 133.28% |
| Ikena Oncology, Inc. | -50.49 Million USD | 10.233% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 141.654% |
| Gossamer Bio, Inc. | -4.38 Million USD | -933.637% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -17886.111% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -906400.0% |
| Legend Biotech Corporation | 140.92 Million USD | 132.162% |
| Mural Oncology plc | -2.56 Million USD | -1665.68% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -8125.953% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -45225.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 318.392% |
| REGENXBIO Inc. | 53.02 Million USD | 185.472% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -746.097% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -23460.754% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -2516.917% |
| Vaxart, Inc. | -60.76 Million USD | 25.407% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -17148.269% |
| Cellectis S.A. | 18 Thousand USD | 251905.556% |
| Longeveron Inc. | 221 Thousand USD | 20609.05% |
| Repare Therapeutics Inc. | -80.07 Million USD | 43.393% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 104.147% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -3402.705% |
| Revolution Medicines, Inc. | -399.66 Million USD | 88.659% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -129400.0% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 92600.0% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.527% |
| Denali Therapeutics Inc. | -93.34 Million USD | 51.444% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -180845.347% |
| Veru Inc. | 7.56 Million USD | 699.067% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -29916.556% |
| Cingulate Inc. | -582.91 Thousand USD | -7675.536% |
| Passage Bio, Inc. | -3.72 Million USD | -1118.087% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -376228.462% |
| Exicure, Inc. | -1.42 Million USD | -3085.172% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -11734.204% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 1776.841% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -8740.884% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 166.531% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -30196.042% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 23.445% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 11692.072% |
| OmniAb, Inc. | 14.66 Million USD | 409.027% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 326.704% |
| Lipocine Inc. | -2.85 Million USD | -1489.895% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -2359.305% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -694.479% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2909.047% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 160.18% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -69630.769% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 153.769% |
| Ocugen, Inc. | -33.53 Million USD | -35.149% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1333.428% |
| Q32 Bio Inc. | 578 Thousand USD | 7941.696% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -17003.774% |
| Alumis Inc. Common Stock | -1.28 Million USD | -3429.984% |
| Equillium, Inc. | 35.95 Million USD | 226.05% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -2555.243% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 9152.706% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1096295.743% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -17400.0% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 10822.43% |
| Dominari Holdings Inc. | 2.03 Million USD | 2322.903% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -24604.177% |
| vTv Therapeutics Inc. | -13.59 Million USD | -233.395% |
| Bio-Techne Corporation | 773.07 Million USD | 105.863% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 361.707% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 109.836% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -3777.246% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -89.012% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 487.493% |
| Nkarta, Inc. | -5.86 Million USD | -672.278% |
| BioCardia, Inc. | -7.24 Million USD | -525.259% |
| Iterum Therapeutics plc | -1.75 Million USD | -2490.0% |